These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 27610565)

  • 1. In Vivo Cellular Reprogramming: The Next Generation.
    Srivastava D; DeWitt N
    Cell; 2016 Sep; 166(6):1386-1396. PubMed ID: 27610565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
    Sadahiro T; Yamanaka S; Ieda M
    Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular roadblocks for cellular reprogramming.
    Vierbuchen T; Wernig M
    Mol Cell; 2012 Sep; 47(6):827-38. PubMed ID: 23020854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
    Xie M; Tang S; Li K; Ding S
    Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion.
    Kwon D; Ji M; Lee S; Seo KW; Kang KS
    Stem Cell Rev Rep; 2017 Feb; 13(1):24-34. PubMed ID: 27817181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo reprogramming for tissue regeneration and organismal rejuvenation.
    Taguchi J; Yamada Y
    Curr Opin Genet Dev; 2017 Oct; 46():132-140. PubMed ID: 28779646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Cell Fate for Tissue Regeneration by In Vivo Transdifferentiation.
    de Lázaro I; Kostarelos K
    Stem Cell Rev Rep; 2016 Feb; 12(1):129-39. PubMed ID: 26403511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical compound-based direct reprogramming for future clinical applications.
    Takeda Y; Harada Y; Yoshikawa T; Dai P
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29739872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.
    Horisawa K; Suzuki A
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(4):131-158. PubMed ID: 32281550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
    Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct reprogramming into desired cell types by defined factors.
    Ieda M
    Keio J Med; 2013; 62(3):74-82. PubMed ID: 23801083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct Cardiac Reprogramming for Cardiovascular Regeneration and Differentiation.
    Sadahiro T; Ieda M
    Keio J Med; 2020 Sep; 69(3):49-58. PubMed ID: 31915320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Future of Direct Cardiac Reprogramming: Any
    López-Muneta L; Miranda-Arrubla J; Carvajal-Vergara X
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor-mediated reprogramming: epigenetics and therapeutic potential.
    Firas J; Liu X; Lim SM; Polo JM
    Immunol Cell Biol; 2015 Mar; 93(3):284-9. PubMed ID: 25643615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells: The growing pains of pluripotency.
    Hayden EC
    Nature; 2011 May; 473(7347):272-4. PubMed ID: 21593837
    [No Abstract]   [Full Text] [Related]  

  • 17. Pluripotent reprogramming and lineage reprogramming: promises and challenges in cardiovascular regeneration.
    He WJ; Hou Q; Han QW; Han WD; Fu XB
    Tissue Eng Part B Rev; 2014 Aug; 20(4):304-13. PubMed ID: 24063625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical transdifferentiation: closer to regenerative medicine.
    Xu A; Cheng L
    Front Med; 2016 Jun; 10(2):152-65. PubMed ID: 27142989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced regeneration--the progress and promise of direct reprogramming for heart repair.
    Addis RC; Epstein JA
    Nat Med; 2013 Jul; 19(7):829-36. PubMed ID: 23836233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
    Ebrahimi B
    Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.